Stockscreener 앱 받기
5.88
121.05%
3.22
시장 영업 전:
5.34
-0.54
-9.18%
전일 마감가:
$2.66
열려 있는:
$5.9
하루 거래량:
124.59M
Relative Volume:
53.22
시가총액:
$192.86M
수익:
-
순이익/손실:
$-87.23M
주가수익비율:
-1.9798
EPS:
-2.97
순현금흐름:
$-82.77M
1주 성능:
+186.83%
1개월 성능:
+348.85%
6개월 성능:
+289.40%
1년 성능:
-31.71%
1일 변동 폭
$4.90
$6.34
1주일 범위
$1.82
$6.34
52주 변동 폭
$0.8801
$9.935
Pepgen Inc Stock (PEPG) Company Profile
명칭
Pepgen Inc
전화
703-456-8000
주소
1 MARINA PARK DRIVE, SUITE 900, BOSTON
PEPG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.88 | 87.25M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-09 | 개시 | Guggenheim | Buy |
| 2024-12-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-07-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-21 | 개시 | H.C. Wainwright | Buy |
Pepgen Inc 주식(PEPG)의 최신 뉴스
PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Form 424B5 PepGen Inc. - StreetInsider
PepGen, Inc. (NASDAQ:PEPG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
PepGen stock price target raised to $12 from $8 at H.C. Wainwright - Investing.com India
PepGen (NASDAQ:PEPG) Given New $12.00 Price Target at Stifel Nicolaus - MarketBeat
S&P 500 Falls 1%; Accenture Posts Upbeat Earnings - Benzinga
Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat
Biotech Small Caps Catch Fire On Clinical And Tech News - Finimize
PepGen Stock Skyrockets Over 110% on Breakthrough DM1 Trial Results - Tokenist
Surge in PepGen Stock: What Investors Need to Know - timothysykes.com
Why Is PepGen Stock (PEPG) Up 125% Today? - TipRanks
Unusually active option classes on open September 25th - TipRanks
Is PepGen the Next Big Investment? - StocksToTrade
PepGen (PEPG) Stock: Biotech Surges 145% on Record DM1 Treatment Results - parameter.io
PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles - Yahoo
Wedbush Forecasts Strong Price Appreciation for PepGen (NASDAQ:PEPG) Stock - MarketBeat
PepGen price target raised to $9 from $7 at Wedbush - TipRanks
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
PepGen (NASDAQ:PEPG) Price Target Raised to $12.00 at HC Wainwright - MarketBeat
HC Wainwright & Co. Maintains PepGen (PEPG) Buy Recommendation - Nasdaq
PepGen price target raised to $12 from $8 at H.C. Wainwright - TipRanks
PepGen stock soars after reporting highest splicing correction in DM1 patients - Investing.com Canada
PepGen announces public offering of common stock and pre-funded warrants - Investing.com Nigeria
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket - Benzinga
PepGen shares more than double after muscle disease drug shows promise in trial - TradingView
PepGen Inc. Announces Positive Phase 1 Study Results - TipRanks
PepGen Prices $100 Million Stock Offering; Shares Soar Pre-Bell - MarketScreener
PepGen (PEPG) Launches $100M Stock Offering to Fund Clinical Trials - GuruFocus
IMRX Soars On Pancreatic Cancer Data, PEPG Sets DM1 Splicing Correction Record, CLPT On Watch - Nasdaq
PepGen Announces Pricing of $100 Million Public Offering - BioSpace
PepGen prices common stock offering at $3.20 per share to raise $100m - Investing.com
PepGen prices 31 million shares at $3.20 per share - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction By Investing.com - Investing.com Australia
PepGen (PEPG) Stock: Soars 119% Following Major Public Offering Proposal - parameter.io
PepGen Reports Highest Mean Splicing Correction in Myotonic Dystrophy Trial; Shares Jump After Hours - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction - Investing.com India
PepGen announces common stock offering, no amount given - TipRanks
PepGen says FREEDOM clinical study achieves all key objectives - TipRanks
PepGen Announces Proposed Public Offering - Business Wire
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Business Wire
PepGen's (PEPG) Buy Rating Reiterated at Guggenheim - MarketBeat
Is PepGen Inc. reversing from oversold territory2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Is PepGen Inc. still worth holding after the dipTrade Risk Assessment & High Conviction Buy Zone Alerts - newser.com
Is PepGen Inc. stock poised for growth2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Can trapped investors hope for a rebound in PepGen Inc.Portfolio Value Report & AI Enhanced Trading Alerts - newser.com
What data driven models say about PepGen Inc.’s futureQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com
Using Bollinger Bands to evaluate PepGen Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
Is PepGen Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Can PepGen (NASDAQ:PEPG) Afford To Invest In Growth? - Yahoo Finance
Pepgen Inc (PEPG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):